Suppr超能文献

在院前门户对无 ST 段抬高的胸痛患者进行快速评估和管理(FamouS Triage):用改良的 HEART 评分在家中排除心肌梗死。

Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score.

机构信息

1 Department of Cardiology, Isala Hospital, The Netherlands.

2 Department of Cardiology, University Hospital Coventry, UK.

出版信息

Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):102-110. doi: 10.1177/2048872616687116. Epub 2017 Jan 13.

Abstract

BACKGROUND

The first study of the FamouS Triage project investigates the feasibility of ruling out a myocardial infarction in pre-hospital chest pain patients without electrocardiographic ST-segment elevation by using the modified HEART score at the patient's home, incorporating only a single highly sensitive troponin T measurement.

METHODS

A venous blood sample was drawn in the ambulance from 1127 consecutive chest pain patients for measurement of the pre-hospital highly sensitive troponin T levels, in order to establish a pre-hospital HEART score (i.e. the modified HEART score) and evaluate the possibility of triage at the patient's home. The primary endpoint was the occurrence of a major adverse cardiac event (MACE) i.e. acute myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting or death within 30 days after initial presentation.

RESULTS

Two hundred and six patients (18%) developed a MACE during 30 days of follow-up. Thirty-six per cent of the patients ( n=403) had a low modified HEART score (0-3 points) and none of them developed a MACE during follow-up. Forty-four per cent of the patients ( n=494) had an intermediate modified HEART score (4-6 points) and 18% of them developed a MACE. Twenty per cent of the patients ( n=230) had a high modified HEART score (7-10 points) of which 52% developed a MACE during follow-up.

CONCLUSION

It seems feasible to rule out a myocardial infarction at home in chest pain patients without ST-segment elevation by using the modified HEART score.

TRIAL ID

NTR4205. Dutch Trial Register [ http://www.trialregister.nl ]: trial number 4205.

摘要

背景

FamouS Triage 项目的第一项研究旨在调查在院前胸痛患者中,通过在家中使用改良 HEART 评分(仅包含单次高敏肌钙蛋白 T 测量)来排除心电图 ST 段抬高型心肌梗死的可行性。

方法

从 1127 例连续胸痛患者的救护车上抽取静脉血样,用于测量院前高敏肌钙蛋白 T 水平,以建立院前 HEART 评分(即改良 HEART 评分)并评估在患者家中分诊的可能性。主要终点是 30 天内发生主要不良心脏事件(MACE)即急性心肌梗死、经皮冠状动脉介入治疗、冠状动脉旁路移植术或死亡。

结果

206 例患者(18%)在 30 天的随访中发生了 MACE。36%的患者(n=403)改良 HEART 评分低(0-3 分),且随访期间均未发生 MACE。44%的患者(n=494)改良 HEART 评分中等(4-6 分),18%发生了 MACE。20%的患者(n=230)改良 HEART 评分高(7-10 分),其中 52%在随访期间发生了 MACE。

结论

似乎可以通过使用改良 HEART 评分在家中排除无 ST 段抬高的胸痛患者的心肌梗死。

试验注册

NTR4205.荷兰试验注册中心[http://www.trialregister.nl]:试验编号 4205。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验